MERIT CRO
MERIT is an innovative clinical endpoint expert providing attentive expertise in our therapeutic areas. We partner with CROs, pharma, and biotech companies to deliver reliable endpoint services in global clinical trials. Together our work advances and accelerates the improvement of therapeutic options for patients worldwide.
We have a proven track record providing endpoint expertise to 13 of the top 20 global pharmaceutical companies. We prioritize a collaborative, partnership-driven approach for all projects with scalable solutions and personalized attention. If you’re looking for a partner that will bring dedication and expertise to your clinical trial, consider MERIT.
What is Idiopathic Pulmonary Fibrosis (IPF)?
What is Interstitial Lung Disease (ILD)?
Mechanisms of Action for IPF Treatments
How are Inflammation & Fibrosis Related?
Interstitial Lung Disease (ILD) Overview Video
New RANO 2.0 & Oncology Trial Endpoints Webinar
Accelerating Retrospective Image Collection with Enhanced PHI De-identification
MERIT: Your Clinical Endpoint Expert
What Makes EXCELSIOR Software Unique?
EXCELSIOR Software Advantages
EXCELSIOR Software Client Benefits
Common Challenge with Reader Monitoring Plans
Effective Reader Monitoring Plans & Variability QC for ADC, IO, CAR-T & Radiopharmaceutical Studies
OCT Imaging with EXCELSIOR
EXCELSIOR Software Modalities
Can AI be used for the interpretation of OCTs?
MERIT Webinar: OCT Evaluation of Neovascular AMD in Clinical Trials – A Reading Center Perspective
MERIT Webinar: Understanding Pseudoprogression - Navigating Neuro-Oncology
MERIT's EXCELSIOR Software Overview & Key Features
Partnerships with MERIT
MERIT's Clinical Endpoint Evaluation & Expertise
AI integration in Radiology Clinical Practice Webinar
MERIT Webinar: Validating Your Imaging Data to Secure Funding
MERIT Webinar: Lugano and Oncology Imaging Endpoints